Genome-wide Analysis of Alternative Pre-mRNA Splicing
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
Alternative splicing of mRNA precursors allows the synthesis of multiple mRNAs from a single primary transcript, significantly expanding the information content and regulatory possibilities of higher eukaryotic genomes. High-throughput enabling technologies, particularly large-scale sequencing and splicing-sensitive microarrays, are providing unprecedented opportunities to address key questions in this field. The picture emerging from these pioneering studies is that alternative splicing affects most human genes and a significant fraction of the genes in other multicellular organisms, with the potential to greatly influence the evolution of complex genomes. A combinatorial code of regulatory signals and factors can deploy physiologically coherent programs of alternative splicing that are distinct from those regulated at other steps of gene expression. Pre-mRNA splicing and its regulation play important roles in human pathologies, and genome-wide analyses in this area are paving the way for improved diagnostic tools and for the identification of novel and more specific pharmaceutical targets.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“with variation in splicing patterns reported in different tissues or at different developmental stages.”
From The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments (2009) · cites this paper as [32]
In the citing paper
“these splicing variants specify alternative protein isoforms”
From The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments (2009) · cites this paper as [32]
In the citing paper
“The transcripts of most human genes and many genes in other multicellular organisms are alternatively spliced (31,32 ),”
From The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments (2009) · cites this paper as [32]
Citations
Cites
Mechanisms of Alternative Pre-Messenger RNA Splicing
Black, D. L. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161720 · Cited by 2,704
Genome-Wide Survey of Human Alternative Pre-mRNA Splicing with Exon Junction Microarrays
Johnson, J. M., Castle, J., Garrett-Engele, P., Kan, Z., Loerch, P. M., Armour, C. D., Santos, R., Schadt, E. E., Stoughton, R., & Shoemaker, D. D. (2003) · Science · doi:10.1126/science.1090100 · Cited by 1,418
Makeyev, E. V., Zhang, J., Carrasco, M. A., & Maniatis, T. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.07.015 · Cited by 1,395
Function of alternative splicing
Stamm, S., Ben-Ari, S., Rafalska, I., Tang, Y., Zhang, Z., Toiber, D., Thanaraj, T. A., & Soreq, H. (2005) · Gene · doi:10.1016/j.gene.2004.10.022 · Cited by 1,377
Understanding alternative splicing: towards a cellular code
Matlin, A. J., Clark, F., & Smith, C. W. J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1645 · Cited by 1,305
Alternative Splicing: New Insights from Global Analyses
Blencowe, B. J. (2006) · Cell · doi:10.1016/j.cell.2006.06.023 · Cited by 1,130
CLIP Identifies Nova-Regulated RNA Networks in the Brain
Ule, J., Jensen, K. B., Ruggiu, M., Mele, A., Ule, A., & Darnell, R. B. (2003) · Science · doi:10.1126/science.1090095 · Cited by 1,120
The gene encoding the splicing factor SF2/ASF is a proto-oncogene
Karni, R., de Stanchina, E., Lowe, S. W., Sinha, R., Mu, D., & Krainer, A. R. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1209 · Cited by 934
Systematic Identification and Analysis of Exonic Splicing Silencers
Wang, Z., Rolish, M. E., Yeo, G., Tung, V., Mawson, M., & Burge, C. B. (2004) · Cell · doi:10.1016/j.cell.2004.11.010 · Cited by 693
Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements
Lareau, L. F., Inada, M., Green, R. E., Wengrod, J. C., & Brenner, S. E. (2007) · Nature · doi:10.1038/nature05676 · Cited by 681
Research works printed but not linked: 3
- Ranum, 2006, Annu. Rev. Neurosci., 291, 257
- Wang, 2003, Cancer Res., 63, 655
- Calarco, J. A., Saltzman, A. L., Ip, J. Y., and Blencowe, B. J. (2007) in Alternative Splicing in the Postgenomic Era (Blencowe, B. J., and Graveley, B. R., eds) pp. 65–85, Landes Bioscience, Austin, TX, in press
Cited by
The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments
Bustin, S. A., Benes, V., Garson, J. A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, T., Pfaffl, M. W., Shipley, G. L., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.112797 · Cited by 16,303
“The transcripts of most human genes and many genes in other multicellular organisms are alternatively spliced (31, 32 ), and these splicing variants specify alternative protein isoforms, with variation in splicing patterns reported in different tissues or at different developmental stages.”
BackgroundPan, Q., Shai, O., Lee, L. J., Frey, B. J., & Blencowe, B. J. (2008) · Nature Genetics · doi:10.1038/ng.259 · Cited by 3,951
HITS-CLIP yields genome-wide insights into brain alternative RNA processing
Licatalosi, D. D., Mele, A., Fak, J. J., Ule, J., Kayikci, M., Chi, S. W., Clark, T. A., Schweitzer, A. C., Blume, J. E., Wang, X., et al. (2008) · Nature · doi:10.1038/nature07488 · Cited by 1,352
“Genome-wide screens have been used to establish correlations between the action of RNABPs and biologic diversity6,7,26-30, but are unable to identify direct sites of RNA regulation.”
Alternative splicing and disease
Tazi, J., Bakkour, N., & Stamm, S. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.09.017 · Cited by 540
“the cell decides whether to remove a part of the pre-mRNA as an intron or include this part in the mature mRNA as an alternative exon [2]; (Fig.”
BackgroundNatural Products: Bioactivity, Biochemistry, and Biological Effects in Cancer and Disease Therapy
Chang, H.-W., Chuang, L.-Y., Guleria, S., & Yasmin, S. (2013) · The Scientific World Journal · doi:10.1155/2013/713480 · Cited by 313
Tilgner, H., Jahanbani, F., Blauwkamp, T., Moshrefi, A., Jaeger, E., Chen, F., Harel, I., Bustamante, C. D., Rasmussen, M., & Snyder, M. P. (2015) · Nature Biotechnology · doi:10.1038/nbt.3242 · Cited by 223
Combinatorial Control of Exon Recognition
Hertel, K. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r700035200 · Cited by 217
Warzecha, C. C., Shen, S., Xing, Y., & Carstens, R. P. (2009) · RNA Biology · doi:10.4161/rna.6.5.9606 · Cited by 205
“Several previous studies have been undertaken to comprehensively profile alternative splicing events regulated by both ubiquitous splicing factors as well as those regulated by cell-type or developmental-stage specific splicing factors.(10,28,29) The splicing regulatory networks characterized in these studies found th…”
BackgroundContext-aware transcript quantification from long-read RNA-seq data with Bambu
Chen, Y., Sim, A., Wan, Y. K., Yeo, K., Lee, J. J. X., Ling, M. H., Love, M. I., & Göke, J. (2023) · Nature Methods · doi:10.1038/s41592-023-01908-w · Cited by 191
“(4) Additional filtering and final annotation output of transcript discovery”
BackgroundRBM5/Luca-15/H37 Regulates Fas Alternative Splice Site Pairing after Exon Definition
Bonnal, S., Martínez, C., Förch, P., Bachi, A., Wilm, M., & Valcárcel, J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.08.008 · Cited by 176
“…Inc. 83 Alternative pre-mRNA splicing significantly contributes to the proteomic diversity of multicellular organisms (Ast, 2005; Blencowe, 2006; Ben-Dov et al., 2008), affecting at least 74% of human multiexon genes (Blencowe, 2006), generating up to thousands of protein isoforms from the…”
BackgroundSelf-citationCurrent-generation high-throughput sequencing: deepening insights into mammalian transcriptomes
Blencowe, B. J., Ahmad, S., & Lee, L. J. (2009) · Genes & Development · doi:10.1101/gad.1788009 · Cited by 168
Emerging roles of RNA and RNA-binding protein network in cancer cells
Kim, M.-Y., Hur, J., & Jeong, S.-J. (2009) · BMB Reports · doi:10.5483/bmbrep.2009.42.3.125 · Cited by 163
“Recent analyses of the human transcriptome have revealed extreme diversity of alternative exons and extensive combinatorial powers of alternative splicing in the human genome ( 18-20 ).”
BackgroundMurphy, J., & Bustin, S. A. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.9.2.187 · Cited by 146
Alternative splicing: global insights
Hallegger, M., Llorian, M., & Smith, C. W. J. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07521.x · Cited by 169
Auto- and Cross-Regulation of the hnRNP L Proteins by Alternative Splicing
Rossbach, O., Hung, L.-H., Schreiner, S., Grishina, I., Heiner, M., Hui, J., & Bindereif, A. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01689-08 · Cited by 141
Handunnetthi, L., Ramagopalan, S. V., Ebers, G. C., & Knight, J. C. (2009) · Genes and Immunity · doi:10.1038/gene.2009.83 · Cited by 157
Evolution of Exon-Intron Structure and Alternative Splicing
Koralewski, T. E., & Krutovsky, K. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018055 · Cited by 146
“[20]), which will help fully understand the effects of this mechanism.”
BackgroundAlternative splicing: role of pseudoexons in human disease and potential therapeutic strategies
Dhir, A., & Buratti, E. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07520.x · Cited by 147
Gonçalves, V., Matos, P., & Jordan, P. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp317 · Cited by 113
The spliceosome as target for anticancer treatment
van Alphen, R. J., Wiemer, E. A. C., Burger, H., & Eskens, F. A. L. M. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604801 · Cited by 104
“A systematic approach using large-scale sequencing and splicing-sensitive microarrays gave for the first time a view of the vast spectrum of alternative transcripts (Blencowe, 2006; Ben-Dov et al, 2008).”
BackgroundMethodWu, C.-S., Yu, C., Chuang, C.-Y., Hsiao, M., Kao, C.-F., Kuo, H., & Chuang, T. (2013) · Genome Research · doi:10.1101/gr.159483.113 · Cited by 108
“Alternative splicing, which arises from post-transcriptional events, can lead to the generation of multiple transcript isoforms from a single gene, thus providing an essential source of diversity for the transcriptome and proteome (Graveley 2001; Maniatis and Tasic 2002; Black and Grabowski 2003; Bracco and Kearsey 20…”
BackgroundSpliceator: multi-species splice site prediction using convolutional neural networks
Scalzitti, N., Kress, A., Orhand, R., Weber, T., Moulinier, L., Jeannin-Girardon, A., Collet, P., Poch, O., & Thompson, J. D. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04471-3 · Cited by 94
“The SS are specifically recognized by the spliceosome, a ribonucleoprotein complex [15], and play an important role in the diversity of the proteome [16, 17].”
BackgroundHandling multi-mapped reads in RNA-seq
Deschamps-Francoeur, G., Simoneau, J., & Scott, M. S. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.06.014 · Cited by 121
“Alternative splicing, as well as the use of alternative promoters, increase the number of different transcripts produced by a gene [29–31].”
BackgroundBlanchette, M., Green, R. E., MacArthur, S., Brooks, A. N., Brenner, S. E., Eisen, M. B., & Rio, D. C. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.01.022 · Cited by 86
“These findings suggest a preferential binding site location for a given factor controlling a specific splice event, as seen previously (Aznarez et al., 2008; Ben-Dov et al., 2008; Blanchette et al., 2005; Castle et al., 2008; Licatalosi et al., 2008; Ule et al., 2006; Zhang et al., 2008).”
Telonis‐Scott, M., Kopp, A., Wayne, M. L., Nuzhdin, S. V., & McIntyre, L. M. (2008) · Genetics · doi:10.1534/genetics.108.096743 · Cited by 100
“AS makes an important contribution to organismal complexity by allowing a single gene to produce multiple, functionally distinct proteins (Graveley 2001; Ben-Dov et al. 2008).”
BackgroundInfluentialRegulation of alternative splicing in Drosophila by 56 RNA binding proteins
Brooks, A. N., Duff, M. O., May, G. E., Yang, L. C., Bolisetty, M. T., Landolin, J. M., Wan, K., Sandler, J. E., Booth, B. W., Celniker, S., et al. (2015) · Genome Research · doi:10.1101/gr.192518.115 · Cited by 95
Post-transcriptional regulation of long noncoding RNAs in cancer
Shi, X., Sun, M., Wu, Y., Yao, Y., Liu, H., Wu, G., Yuan, D., & Song, Y. (2015) · Tumor Biology · doi:10.1007/s13277-015-3106-y · Cited by 85
Promoter-driven splicing regulation in fission yeast
Moldón, A., Malapeira, J., Gabrielli, N., Gogol, M., Gómez‐Escoda, B., Ivanova, T., Seidel, C. W., & Ayté, J. (2008) · Nature · doi:10.1038/nature07325 · Cited by 83
“In humans, at least 70-80% of the genes have introns (Ben-Dov et al., 2008) and in S.”
BackgroundHeat stress induced alternative splicing in catfish as determined by transcriptome analysis
Tan, S., Wang, W., Tian, C., Niu, D., Zhou, T., Jin, Y., Yang, Y., Gao, D., Dunham, R. A., & Liu, Z. (2018) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2018.11.008 · Cited by 86
Excoffon, K. J. D. A., Gansemer, N. D., Mobily, M., Karp, P. H., Parekh, K. R., & Zabner, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009909 · Cited by 75
“regulatory genes, and tissues with diverse cell types [10].”
Calarco, J. A., Zhen, M., & Blencowe, B. J. (2011) · RNA · doi:10.1261/rna.2603911 · Cited by 72
“These platforms typically make use of combinations of short oligonucleotide probes that recognize exon and/or exon junction sequences (Calarco et al. 2007; Ben-Dov et al. 2008; Moore and Silver 2008).”
BackgroundTherapeutic Modulation of RNA Splicing in Malignant and Non-Malignant Disease
El Marabti, E., & Abdel-Wahab, O. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.04.005 · Cited by 71
Decrypting the genome's alternative messages
Hartmann, B., & Valcárcel, J. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.02.006 · Cited by 71
“Global views The advent of high-throughput technologies (Figure 3), including splicing-sensitive microarrays, sequencing of large collections of cDNA/EST libraries and, recently, major advances in our capacity to obtain DNA and RNA sequences, provide a unique momentum for understanding global features of AS [1 ,20,66,…”
BackgroundSelf-citationThe β-catenin/TCF4 pathway modifies alternative splicing through modulation of SRp20 expression
Gonçalves, V., Matos, P., & Jordan, P. (2008) · RNA · doi:10.1261/rna.1253408 · Cited by 75
Li, B. J., Zhu, Z. X., Qin, H., Meng, Z. N., Lin, H., & Xia, J. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00244 · Cited by 73
Implication of the F-Box Protein FBXL21 in Circadian Pacemaker Function in Mammals
Dardente, H., Mendoza, J., Fustin, J., Challet, É., & Hazlerigg, D. G. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003530 · Cited by 70
“It appears that AS is widespread since recent large-scale analyses indicate that as much as 70–80% of genes in mammals are subject to AS [29,31].”
BackgroundArgonaute and the Nuclear RNAs: New Pathways for RNA-Mediated Control of Gene Expression
Gagnon, K. T., & Corey, D. R. (2012) · Nucleic Acid Therapeutics · doi:10.1089/nat.2011.0330 · Cited by 84
“Correlations between disease and alternative splicing exist and will continue to be discovered with the increasing application of high-throughput sequencing technologies (Ben-Dov et al., 2008; Pan et al., 2008).”
Mechaly, A. S., Viñas, J., & Piferrer, F. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.03.004 · Cited by 75
Quantitative regulation of alternative splicing in evolution and development
Irimia, M., Rukov, J. L., Roy, S. W., Vinther, J., & Garcia‐Fernandez, J. (2009) · BioEssays · doi:10.1002/bies.080092 · Cited by 63
The impact of microRNAs and alternative splicing in pharmacogenomics
Passetti, F., Ferreira, C. G., & Costa, F. F. (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2008.14 · Cited by 64
Chang, J., Yang, D.-M., Chang, W.-H., Chow, L., Chan, W.-L., Lin, H.-H., Huang, H.-D., Chang, Y., Hung, C.-H., & Yang, W.-K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018643 · Cited by 64
“Many prior studies of the cellular and molecular biology of cancer have reported the occurrence of aberrant AS of important regulatory genes without mutation; however, genome-wide analyses of aberrant AS in various cancer phenotypes, including tumor initiation and malignant progression, remains incomplete [43].”
Zhang, C., Browne, A., Child, D., DiVito, J. R., Stevenson, J. A., & Tanzi, R. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.079079 · Cited by 56
Yamazaki, T., Wälchli, S., Fujita, T., Ryser, S., Hoshijima, M., Schlegel, W., Kuroda, S., & Maturana, A. D. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq023 · Cited by 54
Biodesign of a renal-protective peptide based on alternative splicing of B-type natriuretic peptide
Pan, S., Chen, H. H., Dickey, D. M., Boerrigter, G., Lee, C. Y. W., Kleppe, L. S., Hall, J. L., Lerman, A., Redfield, M. M., Potter, L. R., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811851106 · Cited by 54
“As alternative splicing usually affects coding regions (11), altered functions of resulting proteins would be predicted.”
BackgroundBarberán-Soler, S., Lambert, N. J., & Zahler, A. M. (2009) · RNA · doi:10.1261/rna.1711109 · Cited by 52
“Genome-wide studies using splicing-sensitive microarrays have shown that AS coupled to NMD regulates many genes in all metazoan genomes studied so far (for review of genomic studies, see Ben-Dov et al. 2008).”
BackgroundAnimal, Fungi, and Plant Genome Sequences Harbor Different Non-Canonical Splice Sites
Sielemann, K., & Pucker, B. (2020) · Cells · doi:10.3390/cells9020458 · Cited by 55
“skipping exons, results in an enor28 mous diversity of synthesized proteins and therefore substantially expands 29 the diversity of products encoded in eukaryotic genomes [3–6].”
BackgroundAlternative splicing: An important mechanism in stem cell biology
Chen, K., Dai, X., & Wu, J. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i1.1 · Cited by 51
RNA‐Seq analysis in mutant zebrafish reveals role of U1C protein in alternative splicing regulation
Rösel, T., Hung, L.-H., Medenbach, J., Donde, K., Starke, S., Beneš, V., Rätsch, G., & Bindereif, A. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.106 · Cited by 53
The function of spliceosome components in open mitosis
Hofmann, J. C., Husedzinovic, A., & Gruß, O. J. (2010) · Nucleus · doi:10.4161/nucl.1.6.13328 · Cited by 47
Emerging technologies for amino acid nutrition research in the post-genome era
Wang, J., Wu, G., Zhou, H., & Wang, F. (2008) · Amino Acids · doi:10.1007/s00726-008-0193-8 · Cited by 48
Hartmann, B., Castelo, R., Blanchette, M., Boue, S., Rio, D. C., & Valcárcel, J. (2009) · Genome Biology · doi:10.1186/gb-2009-10-1-r11 · Cited by 43
“The process of alternative pre-mRNA splicing expands the information content of higher eukaryotic genomes by generating multiple mature mRNAs from a single primary transcript, often with functional consequences [9-11].”
BackgroundSelf-citationGenomic landscape of developing male germ cells
Lee, T., Pang, A. L., Rennert, O. M., & Chan, W. (2009) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.20147 · Cited by 45
“For example, the estimated number of expressed transcripts in humans is 150,000 compared to 32,000 predicted based on the human genome sequence (Ben-Dov et al., 2008).”
BackgroundAlternative Splicing for Diseases, Cancers, Drugs, and Databases
Tang, J., Lee, J., Hou, M., Wang, C., Chen, C., Huang, H., & Chang, H.-W. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/703568 · Cited by 45
“The improvement of high-throughput technologies such as RNASeq [46, 47] and exon arrays [48, 49] is helpful to identify the genome-wide cancer-associated splicing variants.”
BackgroundGrigoryev, Y. A., Kurian, S. M., Nakorchevsky, A., Burke, J. P., Campbell, D., Head, S. R., Deng, J., Kantor, A. B., Yates, J. R., & Salomon, D. R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007906 · Cited by 52
“The majority of what we know about AS is based on conventional single-gene approaches though more recently new technologies to facilitate genome-wide studies have been used [2,34,35,47,50–54].”
MethodHartmann, B., Castelo, R., Miñana, B., Peden, E., Blanchette, M., Rio, D. C., Singh, R., & Valcárcel, J. (2011) · RNA · doi:10.1261/rna.2460411 · Cited by 44
Self-citationU1-independent pre-mRNA splicing contributes to the regulation of alternative splicing
Fukumura, K., Taniguchi, I., Sakamoto, H., Ohno, M., & Inoue, K. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp050 · Cited by 43
Kontos, C. K., & Scorilas, A. (2012) · Gene · doi:10.1016/j.gene.2012.04.084 · Cited by 32
“Therefore, it is considered as a key factor underlying increased cellular and functional complexity in higher eukaryotes (Ben-Dov et al., 2008; Blencowe, 2006; Matlin et al., 2005).”
BackgroundZhu, L., Choudhary, K., González‐Terán, B., Ang, Y.-S., Thomas, R., Stone, N. R., Liu, L., Zhou, P., Zhu, C., Ruan, H., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.057620 · Cited by 35
Co-regulation of alternative splicing by diverse splicing factors in Caenorhabditis elegans
Barberán-Soler, S., Medina, P. E., Estella, J. J., Williams, J. H., & Zahler, A. M. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq767 · Cited by 37
Ghosh, A., Kuppusamy, H., & Pilarski, L. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.013813 · Cited by 30
RNA biomarkers in colorectal cancer
Bustin, S. A., & Murphy, J. (2012) · Methods · doi:10.1016/j.ymeth.2012.10.003 · Cited by 39
Li, Z., Xu, Y., & Lin, Y. (2018) · Gene · doi:10.1016/j.gene.2018.07.027 · Cited by 51
Gavvovidis, I., Rost, I., Trimborn, M., Kaiser, F. J., Purps, J., Wiek, C., Hanenberg, H., Neitzel, H., & Schindler, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040387 · Cited by 31
“Alternative splicing of pre-mRNA allows the formation of multiple transcripts from a single gene, contributes to proteome diversity, and provides a level of gene regulation [43].”
BackgroundSystematic evaluation of the effect of common SNPs on pre-mRNA splicing
ElSharawy, A., Hundrieser, B., Brosch, M., Wittig, M., Huse, K., Platzer, M., Becker, A., Simon, M., Rosenstiel, P., Schreiber, S., et al. (2009) · Human Mutation · doi:10.1002/humu.20906 · Cited by 28
The Supraspliceosome — A Multi-Task Machine for Regulated Pre-mRNA Processing in the Cell Nucleus
Shefer, K., Sperling, J. M., & Sperling, R. (2014) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2014.09.008 · Cited by 34
Novel 5‐lipoxygenase isoforms affect the biosynthesis of 5‐lipoxygenase products
Boudreau, L. H., Bertin, J. O., Robichaud, P. P., Laflamme, M., Ouellette, R. J., Flamand, N., & Surette, M. E. (2010) · The FASEB Journal · doi:10.1096/fj.10-173856 · Cited by 27
“It is now accepted that most genes in the human genome can be subjected to alternative splicing of pre-mRNA transcripts, resulting in protein isoforms with altered biological properties, including changes in catalytic ability, subcellular localization, or interactions with other molecules (30, 31).”
BackgroundThe quest for a message: budding yeast, a model organism to study the control of pre-mRNA splicing
Meyer, M., & Vilardell, J. (2008) · Briefings in Functional Genomics and Proteomics · doi:10.1093/bfgp/elp002 · Cited by 29
“Armed with this tool, several laboratories have set out to study the global effect on splicing of a large set of splicing factors (see [52] for a review).”
BackgroundWu, C.-T., Chiou, C.-Y., Chiu, H.-C., & Yang, U. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-438 · Cited by 23
“Legendre et al. [10] hypothesized that some of the shorter MRE-free transcripts may escape from microRNAmediated inhibition and further observed that alternative cleavage and polyadenylation (APA) reduces the amount of MRE-containing isoforms in the corresponding microRNA-expressed tissue.”
BackgroundInfluentialAPEX1 regulates alternative splicing of key tumorigenesis genes in non-small-cell lung cancer
Peng, L. J., Liu, Y., Chen, J., Du, X., Zhang, R., Chen, M., Wu, Y., Shen, D., Zhong, Y., Shen, D., et al. (2022) · BMC Medical Genomics · doi:10.1186/s12920-022-01290-0 · Cited by 23
“Page 10/29 study support the hypothesis that APEX1 is cancer-promoting and that AS of cancer-related genes has a critical impact on lung cancer cell biology [30].”
Backgroundde Navas, L. F., Reed, H. C., Akam, M. E., Barrio, R., Alonso, C. R., & Sánchez‐Herrero, E. (2010) · Development · doi:10.1242/dev.051409 · Cited by 24
“…melanogaster, and about two-thirds of mouse and human genes, encode alternatively spliced mRNA sequences (Johnson et al., 2003; Stolc et al., 2004; Park and Gravely, 2007; Ben-Dov et al., 2008), the functional relevance of the majority of alternative splicing events remains to be established.”
BackgroundARH: predicting splice variants from genome-wide data with modified entropy
Rasche, A., & Herwig, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp626 · Cited by 24
Identification of a variant form of tyrosine phosphatase LYP
Wang, S., Dong, H., Han, J., Ho, W., Fu, X., & Zhao, Z. J. (2010) · BMC Molecular Biology · doi:10.1186/1471-2199-11-78 · Cited by 20
“On the other hand, alternative splicing of mRNA may generate protein isoforms of different sizes with different biological properties such as protein/protein interaction, subcellular localization, and catalytic activity [19,20].”
Fedor, M. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r700046200 · Cited by 20
Identifying Alternative Hyper-Splicing Signatures in MG-Thymoma by Exon Arrays
Soreq, L., Gilboa-Geffen, A., Berrih‐Aknin, S., Lacoste, P., Darvasi, A., Soreq, E., Bergman, H., & Soreq, H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002392 · Cited by 20
“Additional ENSEMBL EST-based transcripts [6] of COL11A1 are shown below it.”
BackgroundInfluentialEvolution of a tissue-specific splicing network
Taliaferro, J. M., Alvarez, N. S., Green, R. E., Blanchette, M., & Rio, D. C. (2011) · Genes & Development · doi:10.1101/gad.2009011 · Cited by 25
Genome-wide activation of latent donor splice sites in stress and disease
Nevo, Y., Kamhi, E., Jacob‐Hirsch, J., Amariglio, N., Rechavi, G., Sperling, J. M., & Sperling, R. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks834 · Cited by 18
Integration of TE Induces Cancer Specific Alternative Splicing Events
Kim, W. R., Park, E. G., Lee, Y. J., Bae, W. H., Lee, D. H., & Kim, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810918 · Cited by 16
“That is, the combination of exons is alternatively determined as the cell decides whether to eliminate a part of the pre-mRNA or include a specific part of the mature mRNA [4].”
BackgroundBustin, S. A. (2008) · Biomarkers in Medicine · doi:10.2217/17520363.2.3.201 · Cited by 18
Li, A., Yu, B.-Y., Chen, F., Gan, H., Yuan, J., Qiu, R., Huang, J.-C., Yang, Z., & Xu, Z. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10083269 · Cited by 19
Qu, A., Bai, Y., Zhang, X., Zeng, J., Pu, F., Wu, L., Xu, P., & Zhou, T. (2022) · Marine Biotechnology · doi:10.1007/s10126-022-10133-z · Cited by 15
“Alternative splicing (AS), which removes introns from eukaryotic transcripts, plays an essential role in gene expression, and through the generation of numerous alternatively spliced transcript isoforms from the limited set of genes, AS enhances regulatory capacities and proteomic complexities of eukaryotes (Claudia e…”
BackgroundHaque, A., Buratti, E., & Baralle, F. E. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp1040 · Cited by 16
“In fact, global analyses of splicing events (8,9) and the search for these splicing regulatory motifs embedded within exons has received considerable attention, especially through the use of high-throughput and bioinformatics approaches (10,11).”
BackgroundHsu, J. B., Bretaña, N. A., Lee, T.-Y., & Huang, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027567 · Cited by 16
“Due to the importance of splicing factors in pre-mRNA splicing, more attention is being paid to mass spectrometry-based proteomic studies [19,24,25,26,27], which has been observed to identify an increasing number of experimentally verified splicing factors.”
BackgroundMalhan, D., Basti, A., & Relógio, A. (2022) · npj Systems Biology and Applications · doi:10.1038/s41540-022-00225-w · Cited by 20
“CHG provides the corresponding gene sets for ten cancer hallmarks: (1) Activating invasion and metastasis (1,149 genes), (2) Enabling replicative immortality (308 genes), (3) Evading growth suppressors (709 genes), (4) Evading immune destruction (609 genes), (5) Genome instability and mutation (231 genes), (6) Inducin…”
Blencowe, B. J. (2012) · Biochemistry and Cell Biology · doi:10.1139/o2012-019 · Cited by 18
Fang, M., Jacob, R. B., McDougal, O. M., & Oxford, J. T. (2012) · Protein & Cell · doi:10.1007/s13238-012-2917-5 · Cited by 17
Chen, J., Zhang, S., Chen, G., Deng, X., Zhang, D., Wen, H., Yin, Y., Lin, Z., Zhang, X., & Luo, W. (2022) · Animals · doi:10.3390/ani12212956 · Cited by 27
“Alternative splicing is considered a key factor in the increased cellular and functional diversity and complexity of higher eukaryotes [11,12].”
BackgroundTang, Y., Han, S. P., Kassahn, K. S., Skarshewski, A., Rothnagel, J. A., & Smith, R. (2012) · Journal of Molecular Evolution · doi:10.1007/s00239-012-9533-0 · Cited by 14
Features of CFTR mRNA and implications for therapeutics development
Jackson, J. J., Mao, Y., White, T. R., Foye, C., & Oliver, K. E. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1166529 · Cited by 16
“Intron excision and exon ligation are essential steps in premRNA processing known as splicing (Ben-Dov et al., 2008).”
BackgroundVu, T.-D., Oshima, K., Matsumura, K., Iwasaki, Y., Chiu, M.-T., Nikaido, M., & Okada, N. (2022) · BMC Genomics · doi:10.1186/s12864-022-08609-2 · Cited by 14
“AS, the process by which structurally and functionally distinct mRNAs are generated from a single gene, which ultimately leads to protein variants, has key roles in enhancing regulatory capacities and proteomic complexities in eukaryotes [9].”
The landscape of alternative splicing in buccal mucosa squamous cell carcinoma
Shah, T. M., Patel, A. K., Bhatt, V. D., Tripathi, A. K., Shah, S., Shankar, V., & Joshi, C. G. (2013) · Oral Oncology · doi:10.1016/j.oraloncology.2013.03.431 · Cited by 13
Functional characterization and identification of mouse Rad51d splice variants
Gruver, A. M., Yard, B. D., McInnes, C., Rajesh, C., & Pittman, D. L. (2009) · BMC Molecular Biology · doi:10.1186/1471-2199-10-27 · Cited by 14
“Alternative pre-mRNA splicing is a mechanism responsible for proteome diversity and gene regulation in higher eukaryotes [12-14].”
BackgroundAdamopoulos, P. G., Kontos, C. K., Diamantopoulos, M. A., & Scorilas, A. (2018) · Gene · doi:10.1016/j.gene.2018.08.008 · Cited by 12
Tissue specific peculiarities of vibration-induced hypoxia of the rabbit heart, liver and kidney
Vorobieva, V. V., & Shabanov, P. D. (2016) · Reviews on Clinical Pharmacology and Drug Therapy · doi:10.17816/rcf14146-62 · Cited by 12
DBATE: database of alternative transcripts expression
Bianchi, V., Colantoni, A., Calderone, A., Ausiello, G., Ferrè, F., & Helmer‐Citterich, M. (2013) · Database · doi:10.1093/database/bat050 · Cited by 11
“Through the use of recent high-throughput RNA sequencing technologies (RNA-seq), it has been demonstrated that 95% of multi-exon genes undergo AS in panels of human tissues (3), shaping the expressed transcriptome in various ways (4) and generating an exceedingly complex repertoire of mRNAs (5).”
BackgroundVorobieva, V. V., & Shabanov, P. D. (2019) · Reviews on Clinical Pharmacology and Drug Therapy · doi:10.17816/rcf17359-70 · Cited by 11
RNA splicing: Novel star in pulmonary diseases with a treatment perspective
Niu, Z., Xu, B., Li, X., Sun, J., & Liang, H. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.03.023 · Cited by 13
“…in the process of transcription and also an important cellular mechanism leading to different protein isoforms, through removing the intron of the pre-mRNA by spliceosome and splicing regulatory elements to produce mature RNA and regulating different functions such as growth and development 17 .”
Analysis of splicing patterns by pyrosequencing
Méreau, A., Anquetil, V., Cibois, M., Noiret, M., Primot, A., Vallée, A., & Paillard, L. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp626 · Cited by 10
“An alternative to microarrays for genome-wide analyses of splicing patterns is deep-sequencing of mRNAs within a population (2,29).”
BackgroundAlternative Processing as a Mechanism for Regulating Gene Expression
Louzada, E. S. (2007) · Springer eBooks · doi:10.1007/978-0-387-35640-2_3 · Cited by 9
Wang, Y., Yin, Y., Cong, X., Storey, K. B., & Chen, M. (2022) · Frontiers in Marine Science · doi:10.3389/fmars.2021.815109 · Cited by 9
Rodent-specific alternative exons are more frequent in rapidly evolving genes and in paralogs
Nurtdinov, R., Mironov, A. A., & Gelfand, M. S. (2009) · BMC Evolutionary Biology · doi:10.1186/1471-2148-9-142 · Cited by 8
“Conclusion A popular theory [2-4,25-27] posits that alternative splicing is one of the main mechanisms of increasing protein diversity in eukaryotes.”
Background
Metadata
- Authors
- Ben-Dov, C., Hartmann, B., Lundgren, J., & Valcárcel, J.
- Affiliations
- Centre for Genomic Regulation (ES)
- Institució Catalana de Recerca i Estudis Avançats (ES)
- Corresponding author
- Valcárcel, Juan
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2008-01
- Volume
- 283
- Issue
- 3
- Pages
- 1229-1233
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2047941064
- Cited by
- 151
- References
- 70
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 4 · 2022: 13 · 2021: 7 · 2020: 4 · 2019: 3 · 2018: 5 · 2017: 3 · 2016: 1 · 2015: 5 · 2014: 3 · 2013: 7 · 2012: 12
- FWCI
- 1.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4648 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Keywords
- alternative splicing, genome-wide analysis, splicing regulation, next-generation sequencing, gene expression regulation, splicing factors, human disease, therapeutic target
- MeSH terms
- Animals, Disease, Humans, RNA Precursors, Genome, Human, Alternative Splicing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.